# Pentoxifylline in Children With Malaria

> **NCT00133393** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 50 (—)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT00133393
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 50 (—)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133393, "Pentoxifylline in Children With Malaria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00133393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*